Signal transduction by VEGF receptor-1 wild type and mutant proteins (Q43754731)

26 November 2017

Signal transduction by VEGF receptor-1 wild type and mutant proteins (English)

1 reference

26 November 2017

Ito N

1

1 reference

PubMed ID

11583921

26 November 2017

Huang K

series ordinal

2

1 reference

PubMed ID

11583921

26 November 2017

Claesson-Welsh L

series ordinal

3

1 reference

26 November 2017

1 November 2001

1 reference

26 November 2017

6

1 reference

inferred from page(s)

published in

Cellular Signalling

1 reference

26 November 2017

13

1 reference

26 November 2017

11

1 reference

26 November 2017

849-854

1 reference

A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900209-1

7 January 2021

Vascular endothelial growth factor (VEGF) and its receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900209-1

7 January 2021

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900209-1

7 January 2021

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900209-1

7 January 2021

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900209-1

7 January 2021

Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900209-1

7 January 2021

The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900209-1

7 January 2021

Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900209-1

7 January 2021

VRAP is an adaptor protein that binds KDR, a receptor for vascular endothelial cell growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900209-1

7 January 2021

Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900209-1

7 January 2021

Interactions of FLT-1 and KDR with phospholipase C gamma: identification of the phosphotyrosine binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900209-1

7 January 2021

The phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-1) is a major binding site for PLCgamma

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900209-1

7 January 2021

FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900209-1

7 January 2021

A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900209-1

7 January 2021

10.1016/S0898-6568(01)00209-1

Identifiers

DOI

1 reference

26 November 2017

1 reference

PubMed ID

11583921